Indomethacin Versus Nifedipine for Preterm Labor Tocolysis

Status Completed

Clinical Trial Summary

Indomethacin and Nifedipine are commonly used medications for treatment of pre term labor. This study will compare the efficacy and adverse outcomes of oral nifedipine versus oral indomethacin for preterm labor tocolysis in an effort to identify which drug is most effective.

Patients diagnosed with preterm labor who grant consent will be randomized by the pharmacy to receive oral nifedipine or oral indomethacin. Both the patient and primary medical provider will be blinded to the identity of the study drug. An abdominal ultrasound will be performed in the labor and delivery unit prior to the administration of the tocolytic in order to assess fetal position and fluid level, and to document fetal cardiac activity and movement, and will be repeated at 48 hours post-randomization. Following randomization, the patient will be given either 50 mg oral indomethacin with two pills of placebo, or 3 pills each containing 10 mg oral nifedipine for a total of 30 mg. The patients will then receive either 25 mg of oral indomethacin every 6 hours for 48 hours, or 20 mg of oral nifedipine every 6 hours for 48 hours. Tocolysis beyond 48 hours will not be used.

Clinical Trial Description

Patients presenting between 24-34 weeks gestation diagnosed with preterm labor who grant consent will be randomized by the pharmacy to receive oral nifedipine or oral indomethacin. Both the patient and primary medical provider will be blinded to the identity of the study drug. An abdominal ultrasound will be performed in the labor and delivery unit prior to the administration of the tocolytic in order to assess fetal position and fluid level, and to document fetal cardiac activity and movement, and will be repeated at 48 hours post-randomization. Following randomization, the patient will be given either 50 mg oral indomethacin with two pills of placebo, or 3 pills each containing 10 mg oral nifedipine for a total of 30 mg. The patients will then receive either 25 mg of oral indomethacin every 6 hours for 48 hours, or 20 mg of oral nifedipine every 6 hours for 48 hours. Tocolysis beyond 48 hours will not be used. Antibiotics and steroids for fetal lung maturity will be administered as per standard of care for preterm labor. Maternal side effects and delivery outcomes will be assessed from questionnaires administered by the study team following treatment, and/or from review of the patient's medical records. ;

Study Design

Related Conditions & MeSH terms

Obstetric Labor, Premature

Clinical Trial Details

NCT number	NCT00486824
Study type	Interventional
Source	Stanford University
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	April 2007
Completion date	December 8, 2012

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04404686` - Vaginal Indomethacin for Preterm Labor	Phase 2/Phase 3
Completed	`NCT03267043` - Family Nurture Intervention in the NICU at The Valley Hospital	N/A
Recruiting	`NCT04866342` - Servo Controlled Oxygen Targeting (SCO2T) Study: Masimo vs. Nellcor	N/A
Completed	`NCT00185952` - Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.	N/A
Terminated	`NCT01840228` - Vaginal Progesterone for the Prevention of Preterm Birth in Women With Arrested Preterm Labor	N/A
Completed	`NCT04494529` - Single Dose Antenatal Corticosteroids (SNACS) for Women at Risk of Preterm Birth	Phase 3
Recruiting	`NCT05264779` - The Periviable GOALS Decision Support Tool	N/A
Recruiting	`NCT05670665` - Impact of Threatened Preterm Labour in Fetal Cardiovascular and Metabolic Programming (SHs)
Recruiting	`NCT01317225` - Prevention of Preterm Labor in Patients With a Previous Episode of Threatened Preterm Labor With Progesterone	Phase 3
Recruiting	`NCT05114096` - Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)	Phase 4
Completed	`NCT03211338` - Inflammation and Cell Maturation in Preterm Delivery Placentas - in Vitro and in Vivo Effect of Progesterone	N/A
Completed	`NCT02710474` - Family Nurture Intervention in the NICU	N/A
Terminated	`NCT01286246` - Randomized Controlled Trial of Vaginal Progesterone in Women With Threatened Preterm Labor	Phase 4
Completed	`NCT03129945` - Comparison of Nifedipine Versus Indomethacin for Acute Preterm Labor	N/A
Completed	`NCT04177992` - Servo Controlled Oxygen Targeting Study	N/A
Recruiting	`NCT05685745` - Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Terminated	`NCT02021539` - The Prognostic Value of Cervical Elastography for Identifying Patients at Risk for Preterm Delivery	N/A
Not yet recruiting	`NCT01360034` - Nifedipine Versus Indomethacin in the Treatment of Preterm Labour	Phase 3
Recruiting	`NCT05132829` - Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial	Phase 4
Completed	`NCT04390659` - Myomectomy During Cesarean Section Is This Aright Decision

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.